The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...
Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety ...
At 16 years old, Tia Bee Stokes opened a letter that would change her future, telling her that in 10 to 15 years, she would have leukemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback